Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb3+ Ions
Source abstract
Abstract
The study aimed to synthesize and characterize the magnetic drug carrier modified with terbium (III) ions. The addition of terbium extends the possibilities of their applications for targeted anticancer radiotherapy as well as for imaging techniques using radioisotopes emitting β+, β−, α, and γ radiation. The synthesis of iron oxide nanoparticles stabilized with citrates using the co-precipitation method (IONP @ CA) was carried out during the experimental work. The obtained nanoparticles were used to synthesize a conjugate containing terbium ions and guanosine-5′-monophosphate as an analog of drugs from the thiopurine group. Conjugates and their components were characterized using Transmission Electron Microscopy, infrared spectroscopy, X-ray microanalysis, spectrofluorimetry, and thermogravimetric analysis. The hybrid was also investigated with Langmuir layers to check the interaction with analogs of biological membranes.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Iron oxide chemistry and applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland
Funding
National Science Center
References (49)
Show source-provided references
1. Review on Recent Progress in Magnetic Nanoparticles: Synthesis, Characterization, and Diverse Applications10.3389/fchem.2021.629054 ↗
2. A Comprehensive Review of Magnetic Nanomaterials Modern Day Theranostics10.3389/fmats.2019.00179 ↗
3. Ferrite nanoparticles: Synthesis, characterisation and applications in electronic device10.1016/j.mseb.2016.11.002 ↗
4. Are iron oxide nanoparticles safe? Current knowledge and future perspectives10.1016/j.jtemb.2016.03.017 ↗
5. Malhotra, N., Lee, J.-S., Liman, R.A.D., Ruallo, J.M.S., Villaflores, O.B., Ger, T.-R., and Hsiao, C.-D. (2020). Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review. Molecules, 25.10.3390/molecules25143159 ↗
6. Toxicity of metal and metal oxide nanoparticles: A review10.1007/s10311-020-01033-6 ↗
7. Nano-magnetic particles used in biomedicine: Core and coating materials10.1016/j.msec.2013.01.045 ↗
8. Magnetic Nanoparticles in Cancer Therapy and Diagnosis10.1002/adhm.201901058 ↗
9. Self-Assembled Nanomaterials for Enhanced Phototherapy of Cancer10.1021/acsabm.9b00843 ↗
10. Multifunctional magnetic iron oxide nanoparticles: An advanced platform for cancer theranostics10.7150/thno.42564 ↗
11. Magnetic iron oxide nanoparticles for drug delivery: Applications and characteristics10.1080/17425247.2019.1554647 ↗
12. Magnetic field-assisted selective delivery of doxorubicin to cancer cells using magnetoliposomes as drug nanocarriers10.1088/1361-6528/ab19d3 ↗
13. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications10.1166/jbn.2020.2976 ↗
14. Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives10.1002/adma.201906539 ↗
15. Monoolein cubic phase gels and cubosomes doped with magnetic nanoparticles—Hybrid materials for controlled drug release10.1021/acsami.6b12889 ↗
16. Piehler, S., Dähring, H., Grandke, J., Göring, J., Couleaud, P., Aires, A., Cortajarena, A.L., Courty, J., Latorre, A., and Somoza, Á. (2020). Iron Oxide Nanoparticles as Carriers for DOX and Magnetic Hyperthermia after Intratumoral Application into Breast Cancer in Mice: Impact and Future Perspectives. Nanomaterials, 10.10.3390/nano10061016 ↗
17. Functionalisation of magnetic nanoparticles for applications in biomedicine10.1088/0022-3727/36/13/203 ↗
18. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T1-Weighted Magnetic Resonance Imaging and Chemotherapy10.1021/acsnano.7b04924 ↗
19. Reductant-free synthesis of magnetoplasmonic iron oxide-gold nanoparticles10.1016/j.ceramint.2017.08.063 ↗
20. Synthesis and characterization of Gd3+- and Tb3+-doped iron oxide nanoparticles for possible endoradiotherapy and hyperthermia10.1016/j.jmmm.2019.01.102 ↗
21. Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings10.1038/s41598-018-19628-z ↗
22. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
23. [177Lu]pentixather: Comprehensive preclinical characterization of a first CXCR4-directed endoradiotherapeutic agent10.7150/thno.19119 ↗
24. Majkowska Pilip, A., Gawęda, W., Żelechowska-Matysiak, K., Wawrowicz, K., and Bilewicz, A. (2020). Nanoparticles in Targeted Alpha Therapy. Nanomaterials, 10.10.3390/nano10071366 ↗
25. Endoradiotherapy in cancer treatment--basic concepts and future trends10.1016/j.ejphar.2009.05.035 ↗
26. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukaemia and allied diseases10.1182/blood.V8.11.965.965 ↗
27. The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review
28. The low-energy beta(-) and electron emitter Tb-161 as an alternative to Lu-177 for targeted radionuclide therapy10.1016/j.nucmedbio.2011.02.007 ↗
29. Hall, E.J. (1988). Radiobiology for the Radiologist, Lippincott.10.1016/0360-3016(88)90163-0 ↗
30. Adsorption of Doxorubicin onto Citrate-Stabilized Magnetic Nanoparticles10.1021/jp2095278 ↗
31. Surface effects in maghemite nanoparticles10.1016/j.jmmm.2006.09.011 ↗
32. Static and dynamic magnetic properties of spherical magnetite nanoparticles10.1063/1.1599959 ↗
33. Recent advances of magneto-thermal capabilities of nanoparticles: From design principles to biomedical applications10.1016/j.nantod.2017.02.006 ↗
34. One-Pot Synthesis of Highly Magnetic and Stable Citrate Coated Superparamagnetic Iron Oxide Nanoparticles by Modified Coprecipitation Method10.1088/2631-6331/abcdbc ↗
35. Electronic structure and spectral properties of terbium(III) nitrate complex with hexamethylphosphoramide10.1016/j.saa.2016.12.004 ↗
36. Stress-strain relation in the collapse of Langmuir monolayer of a dimer of disk shaped moiety10.1063/1.3465575 ↗
37. Structure and phase transitions in Langmuir monolayers10.1103/RevModPhys.71.779 ↗
38. Hydrophilic iron oxide nanoparticles probe the organization of biomimetic layers: Electrochemical and spectroscopic evidence10.1016/j.electacta.2016.05.098 ↗
39. Yttrium-Doped Iron Oxide Nanoparticles for Magnetic Hyperthermia Applications10.1021/acs.jpcc.9b11043 ↗
40. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery10.1016/j.addr.2011.03.008 ↗
41. Biologically targeted magnetic hyperthermia: Potential and limitations10.3389/fphar.2018.00831 ↗
42. Iacovita, C., Florea, A., Dudric, R., Pall, E., Moldovan, A.I., Tetean, R., Stiufiuc, R., and Lucaciu, C.M. (2016). Small versus large iron oxidemagnetic nanoparticles: Hyperthermia and cell uptake properties. Molecules, 21.10.3390/molecules21101357 ↗
43. Magnetic Vortex Nanorings: A New Class of Hyperthermia Agent for Highly Efficient In Vivo Regression of Tumors10.1002/adma.201405036 ↗
44. Enhanced synergism of thermo-chemotherapy by combining highly efficient magnetic hyperthermia with magnetothermally-facilitated drug release10.1039/C4NR03384A ↗
45. Enhanced specific absorption rate in silanol functionalized Fe3O4 core–shell nanoparticles: Study of Fe leaching in Fe3O4 and hyperthermia in L929 and HeLa cells10.1016/j.colsurfb.2014.07.019 ↗
46. Cędrowska, E., Pruszyński, M., Gawęda, W., Zuk, M., Krysiński, P., Bruchertseifer, F., Morgenstern, A., Karageorgou, M.A., Bouziotis, P., and Bilewicz, A. (2020). Trastuzumab conjugated superparamagnetic iron oxide nanoparticles labeled with 225AC as a perspective tool for combined α-radioimmunotherapy and magnetic hyperthermia of HER2-positive breast cancer. Molecules, 25.10.3390/molecules25051025 ↗
47. Gawęda, W., Osial, M., Żuk, M., Pękała, M., Bilewicz, A., and Krysinski, P. (2020). Lanthanide-doped SPIONs bioconjugation with trastuzumab for potential multimodal anticancer activity and magnetic hyperthermia. Nanomaterials, 10.10.3390/nano10020288 ↗
48. Żuk, M., Gawęda, W., Majkowska-Pilip, A., Osial, M., Wolski, M., Bilewicz, A., and Krysiński, P. (2021). Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy. Pharmaceutics, 13.10.3390/pharmaceutics13111843 ↗
49. Nieciecka, D., Celej, J., Żuk, M., Majkowska-Pilip, A., Żelechowska-Matysiak, K., Lis, A., and Osial, M. (2021). Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin. Pharmaceutics, 13.10.3390/pharmaceutics13040480 ↗